http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
안영환,고영일,김주희,반가영,이연경,홍가나,진유람,Byung-Joo Choi,Yoo Seob Shin,박해심,예영민 대한의학회 2015 Journal of Korean medical science Vol.30 No.3
Both immediate and delayed hypersensitivity reactions to iodinated contrast media (ICM)are relatively common. However, there are few data to determine the clinical utility ofimmunologic evaluation of ICM. To evaluate the utility of ICM skin testing in patients withICM hypersensitivity, 23 patients (17 immediate and 6 delayed reactions) were enrolledfrom 3 university hospitals in Korea. With 6 commonly used ICM including iopromide,iohexol, ioversol, iomeprol, iopamidol and iodixanol, skin prick (SPT), intradermal (IDT) andpatch tests were performed. Of 10 patients with anaphylaxis, 3 (30.0%) and 6 (60.0%)were positive respectively on SPTs and IDTs with the culprit ICM. Three of 6 patients withurticaria showed positive IDTs. In total, 11 (64.7%) had positive on either SPT or IDT. Threeof 6 patients with delayed rashes had positive response to patch test and/or delayed IDT. Among 5 patients (3 anaphylaxis, 1 urticaria and 1 delayed rash) taken subsequentradiological examinations, 3 patients administered safe alternatives according to the resultsof skin testing had no adverse reaction. However, anaphylaxis developed in the other 2patients administered the culprit ICM again. With 64.7% (11/17) and 50% (3/6) of thesensitivities of corresponding allergic skin tests with culprit ICM for immediate and delayedhypersensitivity reactions, the present study suggests that skin tests is useful for thediagnosis of ICM hypersensitivity and for selecting safe ICM and preventing a recurrence ofanaphylaxis caused by the same ICM.